Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oocyte-specific linker histone H1 (H1FOO, also known as H1.8, H1oo, H1-8) is a variant of the histone H1 family that is predominantly expressed in vertebrate oocytes and early embryos[1]. It is a linker histone that binds to nucleosome-bound DNA at the entry and exit sites of the nucleosome and tethers the two linker DNA regions, contributing to compaction of chromatin into higher-order structures[1][3][4]. H1FOO/H1.8 is distinct from the somatic histone H1 variants and is essential for chromosome condensation and segregation during early embryogenesis, particularly by finely regulating the loading of structural chromatin proteins like condensin complexes and topoisomerase II[1]. By modulating the accessibility of these proteins, H1FOO ensures proper chromosome morphology and function, and its absence leads to abnormal chromosome shapes and defective cell division[1]. While it is not a classical therapeutic target such as a receptor or enzyme, H1FOO is crucial for epigenetic regulation and chromatin architecture in oocytes and early embryos[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oocyte-specific linker histone H1 (H1FOO).